Biomaterials intended for wound healing are expected to reduce microbial load while supporting tissue repair in complex wound environments. Plant-mediated synthesis of silver nanoparticles (AgNPs) has attracted interest because plant extracts can provide phytochemicals that mediate nanoparticle reduction, capping, and stabilization. This review critically evaluates recent studies on plant-mediated AgNPs for wound-healing applications, focusing on botanical and extraction variables, synthesis conditions, physicochemical properties, formulation strategies, administered exposure, safety, and biological outcomes. Across the 34 included publications, 14 directly assessed a process-to-property relationship and only two assessed a process-to-performance relationship; none directly assessed a property-to-performance relationship or established a complete process-to-property-to-performance chain. The reviewed studies suggest that plant-mediated AgNPs may reduce microbial burden, modulate inflammation, mitigate oxidative stress, and promote cell migration, re-epithelialization, collagen remodeling, and angiogenesis. However, batch-to-batch variability, incomplete reporting of experimental details, over-reliance on ultraviolet–visible (UV–Vis) spectroscopy for optimization, inadequate evaluation of formulation stability, inconsistent dose reporting, and limited molecular validation of proposed mechanisms remain major factors limiting translation. By evaluating plant-mediated AgNP-based wound-healing systems through a process–property–performance framework, this review summarizes recent advances and highlights key considerations for improving reproducibility, comparability, and translational relevance.
No takes yet. Share an insight, caveat, or question.
Sadeghi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: